Carcinogenic effect of arsenate in C57BL/6J/Han mice and its modulation by different dietary selenium status

Ecotoxicology and Environmental Safety

Volumn 72, Issue 8, 2009, Pages 2143-2152

  Stepnik, Maciej ^a   Stetkiewicz, Jan ^a   Krajnow, Aleksander ^a   Domeradzka, Katarzyna ^a   Gradecka Meesters, Dobrosława ^a   Arkusz, Joanna ^a   Stańczyk, Małgorzata ^a   Palus, Jadwiga ^a   Dziubałtowska, Elzbieta ^a   Sobala, Wojciech ^a   Gromadzińska, Jolanta ^a   Wasowicz, Wojciech ^a   Rydzyński, Konrad ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Arsenate; Carcinogenicity; Diet; Drinking water; Mouse; Selenium

Indexed keywords

ARSENIC ACID; DRINKING WATER; GLUTATHIONE PEROXIDASE; SELENIUM; SODIUM SELENITE;

ARSENATE; CARCINOGEN; CONCENTRATION (COMPOSITION); DIET; DOSE-RESPONSE RELATIONSHIP; DRINKING WATER; MORTALITY; PLASMA; RISK ASSESSMENT; RODENT; SELENIUM; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; C57BL 6 MOUSE; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIETARY INTAKE; ERYTHROCYTE LEVEL; FEMALE; HISTOPATHOLOGY; LYMPHOMA; MORTALITY; MOUSE; NONHUMAN; OVERALL SURVIVAL; SURVIVAL RATE;

ANIMALS; ARSENATES; CARCINOGENICITY TESTS; CARCINOGENS; DIET; DRINKING; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; LYMPHOMA; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEOPLASMS, EXPERIMENTAL; SELENIUM; WATER POLLUTANTS, CHEMICAL;

ANIMALIA; MUS;

EID: 70350053123     PISSN: 01476513     EISSN: 10902414     Source Type: Journal    
DOI: 10.1016/j.ecoenv.2009.06.005     Document Type: Article

References (63)

1. Ahmad S., Kitchin K.T., and Cullen W.R. Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382 (2000) 195-202
2. Ahmad S., Kitchin K.T., and Cullen W.R. Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicol. Lett. 133 (2002) 47-57
3. Babich H., Martin-Alguacil N., and Borenfreund E. Arsenic-selenium interactions determined with cultured fish cells. Toxicol. Lett. 45 (1989) 157-164
4. Berry J.P., and Galle P. Selenium-arsenic interaction in renal cells: role of lysosomes. Electron microprobe study. J. Submicrosc. Cytol. Pathol. 26 (1994) 203-210
5. Biswas S., Talukder G., and Gharma A. Prevention of cytotoxic effects of arsenic by short-term dietary supplementation with selenium in mice in vivo. Mutat. Res. 441 (1999) 155-160
6. Blackwell B.N., Bucci T.J., Hart R.W., and Turturro A. Longevity, body weight, and neoplasia in ad libitum-fed and diet-restricted C57BL6 mice fed NIH-31 open formula diet. Toxicol. Pathol. 23 (1995) 570-582
7. Brown H., and Prescott R. Applied Mixed Models in Medicine (2001), John Wiley & Sons, Ltd., Chichester, England
8. Chen Y., Hall M., Graziano J.H., Slavkovich V., Geen A., Parvez F., and Ahsan H. A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 207-213
9. Clark L.C., Combs Jr. C.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher Jr. J.L., Park J.K., Sanders Jr. B.B., Smith C.L., and Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276 (1996) 1957-1963
10. Cohen S.M., Ohnishi T., Arnold L.L., and Le X.C. Arsenic-induced bladder cancer in an animal model. Toxicol. Appl. Pharmacol. 222 (2007) 258-263
11. Cui X., Wakai T., Shirai Y., Hatakeyama K., and Hirano S. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol. Sci. 91 (2006) 372-381
12. Davis C.D., Uthus E.O., and Finley J.W. Dietary selenium and arsenic affect DNA methylation in vitro in caco-2 cells and in vivo in rat liver and colon. J. Nutr. 130 (2000) 2903-2909
13. El-Bayoumy K., Sinha R., Pinto J.T., and Rivlin R.S. Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J. Nutr. 136 3 Suppl. (2006) 864S-869S
14. Frith, C.H., Ward, J.M., Turusow, V.S., 1994. Tumours of the liver. In: Turusow, V.S., Mohr, U. (Eds.), Pathology of Tumours in Laboratory Animals, Volume II -Tumours of the Mouse. IARC Scientific Publications No. 111, Lyon, pp. 223.
15. Gailer J., Ruprecht L., Reitmeir P., Benker B., and Schramel P. Mobilization of exogenous and endogenous selenium to bile after the intravenous administration of environmentally relevant doses of arsenite to rabbits. Appl. Organometallic Chem. 18 (2004) 670-675
16. Grambsch P., and Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515-526
17. Hayashi H., Kanisawa M., Yamanaka K., Ito T., Udaka N., Ohji H., Okudela K., Okada S., and Kitamura H. Dimethylarsinic acid, a main metabolite of inorganic arsenics, has tumorigenicity and progression effects in the pulmonary tumors of A/J mice. Cancer Lett. 125 (1998) 83-88
18. Hughes M.F., and Kitchin K.T. Arsenic, oxidative stress and carcinogenesis. In: Singh K.K. (Ed). Oxidative Stress, Disease and Cancer (2006), Imperial College Press, London 825-850
19. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004. Some drinking-water disinfectants and contaminants, including arsenic. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 84, IARC, Lyon, France, p. 228.
20. International Agency for Research on Cancer. Preamble to the IARC Monographs (amended January 2006) (2006), IARC, Lyon, France
21. Kibriya M.G., Farzana J., Argos M., Verret W.J., Rakibuz-Zaman M., Parvez A.A.F., and Ahsan H. Changes in gene expression profiles in response to selenium supplementation among individuals with arsenic-induced pre-malignant skin lesions. Toxicol. Lett. 169 (2007) 162-176
22. Kinoshita A., Wanibuchi H., Wei M., Yunoki T., and Fukushima S. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder. Toxicol. Appl. Pharmacol. 221 (2007) 295-305
23. Li W., Wanibuchi H., Salim E.I., Yamamoto S., Yoshida K., Endo G., and Fukushima S. Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid and organic arsenic compound. Cancer Lett. 134 (1998) 29-36
24. Liu J., Xie Y., Merrick B.A., Shen J., Ducharme D.M.K., Collins J., Diwan B.A., Logsdon D., and Waalkes M.P. Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver. Toxicol. Appl. Pharmacol. 213 (2006) 216-223
25. Manley S.A., George G.N., Pickering I.J., Glass R.S., Prenner E.J., Yamdagni R., Wu Q., and Gailer J. The seleno bis(S-glutathionyl) arsinium ion is assembled in erythrocyte lysate. Chem. Res. Toxicol. 19 (2006) 601-607
26. Melnick R.L., Thayer K.A., and Bucher J.R. Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies. Environ. Health Perspect. 116 (2008) 130-135
27. Mizoi M., Takabayashi F., Nakano M., An Y., Sagesaka Y., Kato K., Okada S., and Yamanaka K. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress. Toxicol. Lett. 158 (2005) 87-94
28. Moore L.E., Lu M., and Smith A.H. Childhood cancer incidence and arsenic exposure in drinking water in Nevada. Arch. Environ. Health 57 (2002) 201-206
29. Nesnow S., Roop B.C., Lambert G., Kadiiska M., Mason R.P., Cullen W.R., and Mass M.J. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15 (2002) 1627-1634
30. Neve J., Chamart S., and Molle L. Optimization of a direct procedure for the determination of selenium in plasma and erythrocytes using Zeeman effect atomic absorption spectroscopy. In: Bratter P., and Schramel P. (Eds). Analytical Chemistry in Medicine and Biology vol. 4 (1987), Walter de Gruyter 349-358
31. Ng J.C., Seawright A.A., Qi L., Garnet C.M., Chiswell B., and Moore M.R. Tumours in mice induced by exposure to sodium arsenate in drinking water. In: Chappell W.R., Abernathy C.O., and Calderon R.L. (Eds). Arsenic Exposure and Health Effects (1999), Elsevier Science, Amsterdam 217-223
32. Paglia D.E., and Valentine V.W. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
33. Palus J., Lewińska D., Dziubałtowska E., Wa{ogonek}sowicz W., Gromadzińska J., Rydzyński K., Stańczyk M., Arkusz J., Trzcinka-Ochocka M., and Ste{ogonek}pnik M. Genotoxic effects in C57BL/6J mice chronically exposed to arsenate in drinking water and modulation of the effects by low-selenium diet. J. Toxicol. Environ. Health A 69 (2006) 1843-1860
34. R Development Core Team. R: A language and environment for statistical computing (2007), R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org ISBN:3-900051-07-0, URL, http://www.R-project.org
35. Richardson D.B., Terschüren C., and Hoffmann W. Occupational risk factors for non-Hodgkin's lymphoma: a population-based case-control study in Northern Germany. Am. J. Ind. Med. 51 (2008) 258-268
36. Richie J.P., Kleinman W., Desai D.H., Das A., Amin S.G., and Pinto J.T. The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis and enhances glutathione-related antioxidant levels in A/J mouse lung. Chem.-Biol. Interact 161 (2006) 93-103
37. Rossman T.G., and Uddin A.N. Selenium prevents spontaneous and arsenite-induced mutagenesis. Int. Congr. Ser. 1275 (2004) 173-179
38. Salim E.I., Wanibuchi H., Morimura K., Wei M., Mitsuhashi M., Yoshida K., Endo G., and Fukushima S. Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice. Carcinogenesis 24 (2003) 335-342
39. Schrauzer G.N., White D.A., McGinness J.E., Schneider C.J., and Bell L.J. Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbred female C3H/St mice. Bioinorg. Chem. 9 (1978) 245-253
40. Styblo M., and Thomas D.J. Selenium modifies the metabolism and toxicity of arsenic in primary rat hepatocytes. Toxicol. Appl. Pharmacol. 172 (2001) 52-61
41. Sweins A. Protective effect of selenium against arsenic-induced chromosomal damage in cultured human lymphocytes. Hereditas 98 (1983) 249-252
42. Tapio S., and Grosche B. Arsenic in the aetiology of cancer. Mutat. Res. 612 (2006) 215-246
43. Therneau T.M., and Grambsch P.M. Modeling Survival Data. Extending the Cox model (2001), Springer-Verlag, New York
44. Tsai S.M., Wang T.N., and Ko Y.C. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health 54 (1999) 186-193
45. Uddin A.N., Burns F.J., and Rossman T.G. Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin. Carcinogenesis 26 (2005) 2179-2186
46. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 181-182 (2002) 211-217
47. Verret W.J., Chen Y., Ahmed A., Islam T., Parvez F., Kibriya M.G., Graziano J.H., and Ahsan H. A randomized, double-blind placebo-controlled trial evaluating the effects of vitamin E and selenium on arsenic-induced skin lesions in Bangladesh. J. Occup. Environ. Med. 47 (2005) 1026-1035
48. Waalkes M.P., Liu J., and Diwan B.A. Transplacental arsenic carcinogenesis in mice. Toxicol. Appl. Pharmacol. 222 (2007) 271-280
49. Waalkes M.P., Ward J.M., and Diwan B.A. Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: promotional effects of postnatal phorbolester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25 (2004) 133-141
50. Walton F.S., Waters S.B., Jolley S.L., LeCluyse E.L., Thomas D.J., and Styblo M. Selenium compounds modulate the activity of recombinant rat AsIII-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem. Res. Toxicol. 16 (2003) 261-265
51. Wanibuchi H., Yamamoto S., Chen H., Yoshida K., Endo G., Hori T., and Fukushima S. Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats. Carcinogenesis 17 (1996) 2435-2439
52. Watkinson J.H. Fluorometric determination of selenium in biological material with 2,3-diaminonaphthalene. Anal. Chem. 38 (1966) 92-97
53. Wei M., Wanibuchi H., Morimura K., Iwai S., Yoshida K., Endo G., Nakae D., and Fukushima S. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23 (2002) 1387-1397
54. Wei M., Wanibuchi H., Yamamoto S., Li W., and Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20 (1999) 1873-1876
55. Wong H.K., Riondel J., Ducros V., Ballester B., Mathieu J., and Favier A. Effects of selenium supplementation on malignant lymphoproliferative pathologies associated with OF1 mouse ageing. Anticancer Res. 21 1A (2001) 393-402
56. Yamamoto S., Konishi Y., Matsuda T., Murai T., Shibata M.A., Matsui-Yuasa I., Otani S., Kuroda K., Endo G., and Fukushima S. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid) inF344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55 (1995) 1271-1276
57. Yamanaka K., Kato K., Mizoi M., An Y., Nakanao M., Hoshino M., and Okada S. Dimethylarsine likely acts as a mouse-pulmonary tumor initiator via the production of dimethylarsine radical and/or its peroxy radical. Life Sci. (2009) 10.1016/j.lfs.2009.02.008
58. Yamanaka K., Katsumata K., Ikuma K., Hasegawa A., Nakano M., and Okada S. The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett. 152 (2000) 79-85
59. Yamanaka K., Mizoi M., Kato K., Hasegawa A., Nakano M., and Okada S. Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Biol. Pharm. Bull. 24 (2001) 510-514
60. Yamanaka K., Ohtsubo K., Hasegawa A., Hayashi H., Ohji H., Kanisawa M., and Okada S. Exposure to dimethylarsinic acid, a main metabolite of inorganic arsenics, strongly promotes tumorigenes is initiated by 4-nitroquinoline1-oxide in the lungs of mice. Carcinogenesis 17 (1996) 767-770
61. Yamanoshita O., Ichihara S., Hama H., Ichihara G., Chiba M., Kamijima M., Takeda I., and Nakajima T. Chemopreventive effect of selenium-enriched Japanese radish sprout against breast cancer induced by 7,12-dimethylbenz[a]anthracene in rats. Tohoku J. Exp. Med. 212 (2007) 191-198
62. Yang L., Wang W., Hou S., Peterson P.J., and Williams W.P. Effects of selenium supplementation on arsenism: an intervention trial in inner Mongolia. Environ. Geochem. Health 24 (2002) 359-374
63. Zeng H., Uthus E.O., and Combs G.F. Mechanistic aspects of the interaction between selenium and arsenic. J. Inorg. Biochem. 99 (2005) 1269-1274